Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
Journal: Gastrointestinal endoscopy
Published: January 23, 2018
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors.
Journal: Postgraduate medicine
Published: February 11, 2016
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.
Journal: Journal of Crohn's & colitis
Published: November 26, 2015
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.
Journal: Journal of clinical gastroenterology
Published: September 15, 2015
Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: July 01, 2015
Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.
Journal: Alimentary pharmacology & therapeutics
Published: December 19, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026